Plasmodial Kinase Inhibitors Targeting Malaria: Recent Developments

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Artemisinin-resistant malaria poses a significant global health threat.
• Novel therapeutic strategies are urgently needed to combat malaria.
• Plasmodial kinases are validated drug targets for antimalarial development.

Purpose of the Study:

• To systematically review recently developed molecules targeting Plasmodium kinases.
• To assess the therapeutic potential of kinase inhibitors for malaria treatment.
• To identify unexplored areas within the Plasmodium kinome for future drug discovery.

Main Methods:

• Systematic literature review of CAPLUS and MEDLINE databases (2005-2020).
• Analysis of compounds targeting Plasmodium kinases.
• Identification of novel antimalarial drug candidates.

Main Results:

• Over one hundred compounds targeting 22 Plasmodium kinases were identified.
• MMV390048, a plasmodial kinase inhibitor, represents a promising therapeutic candidate.
• Significant progress has been made in developing kinase inhibitors for malaria.

Conclusions:

• Compounds targeting Plasmodium kinases show strong potential for future malaria drug therapies.
• Further exploration of the Plasmodium kinome is warranted.
• Kinase inhibition represents a viable strategy to overcome drug resistance in malaria.